相关实验视频
Updated: Jul 9, 2025

06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
5.4K
近期更新的Venetoclax组合疗法在儿童血液恶性瘤中的最新更新
Maria Leśniak1, Justyna Lipniarska1, Patrycja Majka1
1Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
International journal of molecular sciences
|December 9, 2023
概括
威尼托克拉克斯在治疗儿科白血病方面表现有前途,显示出与成年人相似的可容忍安全概况. 需要进一步的研究,以优化其在患有血液性恶性瘤的年轻患者的使用.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 维内托克拉克斯 (BCL-2 抑制剂) 有效地治疗成人血液性恶性瘤.
- 它在儿科血液学中的有效性和安全性尚未完全确立.
- 新兴研究探讨了venetoclax在儿科瘤学中的作用.
研究的目的:
- 评估venetoclax在治疗儿科血液性恶性瘤中的潜力.
- 评估基于venetoclax的治疗方案在儿童中的安全性和耐受性.
- 为了确定venetoclax在小儿患者初级和耐火性急性白血病中的活性.
主要方法:
- 在儿童群体中使用venetoclax的临床前和临床试验的审查.
- 对接受venetoclax组合治疗的儿科患者的安全性概况和不良事件的分析.
- 研究venetoclax的活性与标准化疗和高剂量化疗相结合.
主要成果:
- 维尼托克拉克斯联合治疗在儿科患者中似乎耐受良好,安全性概况与成年人相似.
- 在儿科病例中,严重的感染是显著的副作用.
- 研究表明,在年轻患者中对急性白血病有潜在的活性.
结论:
- 威尼托克拉克斯显示出作为治疗小儿血液恶性瘤的治疗剂的潜力.
- 最佳疗法和长期结果需要进一步研究.
- 基于Venetoclax的治疗可能为儿科瘤学提供新的治疗途径.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

